Αποτελέσματα Αναζήτησης
21 Απρ 2023 · Of the pathogenic Klebsiella species, K. pneumoniae is the most prevalent and clinically important. Infections with K. pneumoniae are usually hospital-acquired and occur primarily in patients with impaired host defenses.
- Keri K Hall, Md, Ms
Clinical features, diagnosis, and treatment of Klebsiella...
- Tsay Rw, SIU Lk, Fung Cp, Chang Fy. Characteristics of Bacteremia Between Community-Acquired and Nosocomial Klebsiella Pneumoniae Infection: Risk Factor for Mortality and The Impact of Capsular Serotypes as a Herald for Community-Acquired Infection. Arch Intern Med 2002; 162:1021
Klebsiella pneumoniae liver abscesses, which were all...
- Keri K Hall, Md, Ms
20 Ιουλ 2023 · Identify the most common cause of hospital-acquired pneumonia in the United States. Recall patients most likely to get Klebsiella pneumonia. Review the evaluation and treatment of patients with Klebsiella pneumonia and the interprofessional team's role in managing patients with this condition.
The optimal approach to the treatment of infections caused by these multidrug-resistant strains remains undefined, and treatment decisions for an individual patient should be based on a number of organism- (for example, minimum inhibitory concentration) and patient-specific (for example, site of infection) factors.
27 Νοε 2023 · This protocol illustrates an optimized method to visualize purified K. pneumoniae extracellular polysaccharide by SDS-PAGE using a combination of Alcian blue and silver stain. The combination staining protocol was adapted to K. pneumoniae extracellular polysaccharide from previously described methods (Khadka et al., 2023 ; Ovchinnikova et al ...
The aim of this review is to discuss the challenges in the management and treatment of patients with infections because of K. pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) and provide an expert opinion. Table 1. Species distribution of Class A KPC. Modified by Miriagou and colleagues. 2. Open in a new tab.
18 Αυγ 2022 · Summary. We retrospectively analyzed published data on the use and outcomes of antimicrobial therapy for K. pneumoniae infections. We discussed plazomicin, eravacycline, fosfomycin, tigecycline, and polymyxin as prevalent therapeutic options.
9 Μαΐ 2017 · The optimal management of KPC-KP infections in critically ill patients relies on a concerted multidisciplinary approach. On a case-by-case basis, efforts should indeed be directed towards preventing colonization, infection and mortality.
